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Abstract
Background: Composing of less than 1% of all ovarian cancers, immature teratoma is a malignancy that mainly
affects the young, and they present with advanced disease. The treatment of immature teratoma is conservative
primary surgery usually involving unilateral salpingo-oophorectomy followed by combination chemotherapy.
Case presentation: Here we present a case of a 68 year old woman with bilateral ovarian teratoma complicated
with carcinosarcoma. The patient was diagnosed as FIGO stage IIIC. She underwent neoadjuvant chemotherapy
and interval cytoreduction followed by optimal cytoreduction. The post operative management strategies and
gynaecological follow up studies revealed no evidence of regional or distant metastasis.
Conclusion: Thus the choice of initial treatment should be decided in a selective fashion depending on various
prognostic factors in order to increase the survival of the patients.
Background
The term teratoma was derived from the Greek root tera-
tos which means Monster [1]. Teratomas are the most
common germ cell tumours (GCTs) composing of two or
more germ layers (ectoderm, mesoderm or endoderm),
derived from a pluripotent malignant precursor cell.
Mature teratomas consist of adult-type differentiated
components such as cartilage and glandular epithelium
and immature teratomas contain tissues with partial
somatic differentiation similar to that in foetal tissues [2].
Composing of less than 1% of all ovarian cancers, imma-
ture teratoma is rapidly progressing without treatment.
The average age at diagnosis of this non-dysgerminatous
tumour is 19 years. The symptoms are often non-specific,
usually consisting of mass effect inflicting abdominal/
pelvic discomfort [3]. The foundations of treatment for
immature teratoma have been steadfast throughout dec-
ades: conservative primary surgery usually involving uni-
lateral salpingo-oophorectomy followed by combination
chemotherapy. We present here a patient with bilateral
ovarian teratoma complicated with carcinosarcoma at the
age of 68. Women at this age group are less likely to be
optimally debulked, more likely to have high rates of che-
motherapeutic toxicity and high rate of medical co-mor-
bidities [4,5]. Taking into account all these considerations
the present study was formulated to determine the impact
and success of neoadjuvant chemotherapy and interval
cytoreduction in the treatment of ovarian teratoma in an
old age woman.
Case presentation
A 68 year old lady was referred to oncology outpatients
in January 2010, with a month history of severe abdom-
inal pain. Her past clinical history included no tubal
ligation or hormone replacement therapy. She had pre-
viously given birth to a female child at her age of 21.
The patient was fit and well with no significant past
medical history apart from hypertension and diabetes.
There was no family history of breast or ovarian
carcinoma.
Physical examination revealed an abdominal pelvic
mass with ascites and omental deposits. Blood analysis
showed haemoglobin concentration of 11.3 g/dl while
the rest of the analysis were normal including the carci-
noembryonic antigen (CEA), alphafetoprotein and Can-
cer Antigen-125 (CA-125) (1.25 U/ml). The cytological
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composing of mixed inflammatory cells admixed with
papillary and acinar clusters of eosinophilic cells with
pleomorphic hyperchromatic nuclei thus suggesting a
metastatic carcinoma.
Pelvic sonogram revealed a large tumour mass with
solid and cystic components. Minimal ascites was noted.
A subsequent computerized tomography (CT) scan of
the abdomen and pelvis revealed heterogeneously
enhancing mass lesion measuring 9 × 7.1 cm with solid
and cystic areas and calcification in the retrovesical
region (Figure 1A). The mass was found to be compres-
sing on the right lower ureter leading to right hydrodeu-
teronephrosis. Multiple enlarged peritoneal nodules with
a largest one measuring 10 × 6.3 cm were observed.
Moderate free fluid in abdomen and pelvis with moder-
ate right pleural effusion was observed. The diagnosis of
the malignant transformation was suggested by the inva-
sive growth of soft tissue components through the tera-
toma wall by CT scan images. Finally based on the
clinical manifestations she was diagnosed as having
FIGO stage IIIC of immature teratoma.
Due to unresectable bulky tumours and poor perfor-
mance status the patient underwent neoadjuvant che-
motherapy (NAC) followed by Interval Cytoreductive
Surgery (ICS). Four cycles of combination of paclitaxel
and carboplatin were administered every 3 weeks. ICS
was performed in the 5
th week after administration of
the 4
th cycle of NAC. Standard procedures of ICS con-
sisting of total abdominal hysterectomy, bilateral sal-
pingo-oophorectomy, omentectomy and maximal
debulking of metastatic tumour was adopted. Following
the procedure there was no residual macroscopic disease
and she was transferred to high dependency.
The surface of the tumour appeared rough and con-
gested. On cutting, the ovarian mass was full of sebac-
eous material and hair densely adherent to surrounding
structures. Histopathological examination confirmed
bilateral teratoma complicated with carcinosarcoma
(Figure 1B) with heterogeneous rhabdoid elements
(Figure 1C) Microscopically the left ovarian tumour
displayed variable size cyst lined by multilayered malig-
nant squamous cells (Figure 1D) with rhabdoid spindle
cells, cytoplasmic clearing, mature atypical cartilage
(Figure 1E), malignant tubules, small round cells with
rosettes, bone marrow and neural bundle. In addition
the focal area showed atypical giant bizarre cells. The
observation of the right ovarian tumour displayed
admixture of malignant, epithelial and mesenchymal ele-
ments. The epithelial layers showed variable sized
islands of squamoid and polygonal spindle cells and
rarely showed tubular papillary structure. The stroma
appeared to be a mixture of rhabdoid spindle cells, pri-
mitive mesenchymal cells, neural elements, adipocytic
elements. Focal area showed pigmented cells.
The patient recovered well from surgery and was
referred for oncological follow up and post- surgical
chemotherapy (same regime as NAC). Given her age
and performance status a surveillance approach was
taken with regular clinical examinations, serial tumour
markers and routine CT scans. The follow up studies
showed no evidence of recurrence, regional or distant
metastasis.
Conclusion
The prognosis of immature teratoma heavily depends on
the FIGO stage. The other prognostic factors include
tumour grade, growth pattern, capsular rupture and vas-
cular invasion [6,7]. Age alone has been shown to be an
independent predictor of survival in those with ovarian
cancer [8]. The 2-year disease free survival for grade 1,
grade 2 and grade 3 is 83%, 50% and 33% respectively
[9]. The general consensus in the treatment of stage I
immature teratoma is unilateral salpingo-oophorectomy
of the involved ovary for grade I disease, followed by
adjuvant chemotherapy if tumour is grade 2 or 3
[10,11]. Several controversial arise regarding the stan-
dard treatment of immature teratoma among paediatric/
adolescent population [12,13].
In spite of the controversial in treatment strategy, in
the present study we have presented a rare event of bilat-
eral ovarian teratoma complicated with carcinosarcoma
Figure 1 Clinical observations of the malignant teratoma of
the ovary. A: Computerised tomography of the abdomen, B:
Characteristics of carcinosarcoma, C: Stroma with rhabdoid
elements, D: Malignant changes of squamous layer, E: Stroma with
cartilaginous elements.
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rare event coupled with her age suggests that she was
less likely to be treated with standard therapy [14-16]
and she was less likely to tolerate these treatments when
received [17]. Taking into account her age factor she was
less likely to be optimally debulked and also necessitate a
post operative intensive care stay [18].
Thus in a view point not to worsen the prognosis for
patient with such advanced ovarian cancer, neoadjuvant
chemotherapy followed by interval cytoreduction was
suggested. Thus caring for older women with advanced
ovarian cancers presents unique challenges. Even after
the achievement of optimal cytoreduction the survival
rates are found to be very low. However careful selec-
tion of primary cytoreduction versus neoadjuvant che-
motherapy can result in higher rates of optimal
cytoreduction, low rates of post-operative death. Thus
in patients where optimal debulking is not possible at
presentation, neoadjuvant chemotherapy will be the best
choice of treatment.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
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